ERK1/2/MAPK pathway-dependent regulation of the telomeric factor TRF2

Area of Science:

• Cell Biology
• Molecular Biology
• Cancer Research

Background:

• Telomere stability is essential for cell immortality and cancer progression.
• The Shelterin complex, particularly TRF2 (telomeric repeat binding factor 2), protects telomeres and prevents DNA damage responses.
• TRF2 inhibits the ATM signaling pathway and prevents chromosome end fusion.

Purpose of the Study:

• To investigate the regulation of TRF2 function in normal and cancer cells.
• To identify signaling pathways that control TRF2 activity.
• To explore the therapeutic potential of targeting TRF2 phosphorylation.

Main Methods:

• In vitro and in vivo phosphorylation assays.
• Co-immunoprecipitation to detect protein interactions.
• Expression of non-phosphorylatable TRF2 mutants in melanoma cells.

Main Results:

• TRF2 is phosphorylated on serine 323 by ERK1/2 (extracellular signal-regulated kinase) in vitro and in vivo.
• Activated ERK1/2 and TRF2 interact in the cytoplasm of tumor cells.
• Non-phosphorylatable TRF2 mutants induce DNA damage response, growth arrest, and tumor reversion in melanoma cells.

Conclusions:

• Telomere stability is directly regulated by the pro-oncogenic RAS/RAF/MEK/ERK signaling pathway through TRF2 phosphorylation.
• TRF2 phosphorylation by ERK1/2 is a critical mechanism for maintaining telomere integrity in cancer cells.
• Targeting TRF2 phosphorylation may offer a novel therapeutic strategy for cancer treatment.